Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats

Japanese Journal of Cancer Research : Gann
N YoshimiH Mori

Abstract

Prostaglandin E2, which is produced by cyclooxygenase (COX) during arachidonic acid metabolism, is considered to be related to colon carcinogenesis. Therefore, the effect of NS-398 (N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide), a COX-2 inhibitor, was examined in azoxymethane (AOM)-induced colon carcinogenesis in rats in this study. In the first experiment, groups 1-3 were treated with AOM (15 mg/kg, s.c.) 3 times at intervals of a week from 5 weeks of age. Groups 2 and 3 were respectively given 1 mg/kg and 10 mg/kg of NS-398 in 5% gum arabic aqueous solution 3 times per week by oral gavage during the experiment. Six weeks after the first exposure to AOM, aberrant crypt foci (ACF) were counted in the colonic mucosa of all rats. The mean occurrence of ACF per length in rats given 1 mg/kg b.w. or 10 mg/kg b.w. of NS-398 was reduced to 65.7% or 52.8%, respectively, of that in rats treated with only AOM. Levels of COX-2 mRNA expression in groups treated with AOM, regardless of NS-398, were slightly higher than that in the group treated with NS-398 alone as judged from reverse transcription-polymerase chain reaction analysis. In the second experiment, the effect of NS-398 at different times, i.e., during initiation and post-i...Continue Reading

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T Hla, K Neilson
Dec 15, 1991·The New England Journal of Medicine·M J ThunC W Heath
Mar 6, 1991·Journal of the National Cancer Institute·L RosenbergS Shapiro
Apr 24, 1991·Biochimica Et Biophysica Acta·W L Smith, L J Marnett
Jul 1, 1991·Diseases of the Colon and Rectum·A YamaguchiI Miyazaki
Jun 1, 1985·The American Journal of Medicine·J Carmichael, S W Shankel
Mar 25, 1983·Nucleic Acids Research·U NudelD Yaffe
Oct 1, 1983·The Journal of Clinical Investigation·P A CravenF R DeRubertis
Sep 1, 1984·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H L Corwin, J V Bonventre
Nov 30, 1993·Annals of the New York Academy of Sciences·T HlaJ G Barriocanal
Dec 1, 1993·Archives of Biochemistry and Biophysics·L FengD Hwang
May 6, 1993·The New England Journal of Medicine·F M GiardielloG J Offerhaus
Aug 1, 1993·Japanese Journal of Cancer Research : Gann·S Broder
Jan 1, 1996·Journal of Cancer Research and Clinical Oncology·M TakahashiT Sugimura

❮ Previous
Next ❯

Citations

Jul 2, 1999·The American Journal of Medicine·P E Lipsky
Nov 27, 1999·Pharmacology & Therapeutics·D P Rose, J M Connolly
Apr 7, 2005·Postgraduate Medical Journal·S SanghaM M Wolfe
Jul 5, 2005·Expert Opinion on Investigational Drugs·C S WilliamsR N DuBois
Jan 5, 2001·Expert Opinion on Investigational Drugs·A T KokiJ L Masferrer
Oct 21, 2000·Mayo Clinic Proceedings·N S Buttar, K K Wang
May 21, 2005·Chemico-biological Interactions·Hideki MoriAkira Hara
Oct 13, 2005·Biochimica Et Biophysica Acta·Theresa P Pretlow, Thomas G Pretlow
Apr 2, 2002·The American Journal of Gastroenterology·Syeda S HusainAndrzej S Tamawski
Dec 30, 2006·Journal of Lower Genital Tract Disease·Briana R Benning, Michael R Lund
Nov 15, 2000·Critical Reviews in Clinical Laboratory Sciences·E Fosslien
Oct 3, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·J A Oviedo, M M Wolfe
Feb 11, 2000·Annals of the New York Academy of Sciences·C WilliamsR N DuBois
Feb 14, 2014·The British Journal of Nutrition·Claire ZhangKrista A Power
Dec 25, 2002·The British Journal of Nutrition·John C Mathers
May 7, 2009·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Jayabal PanneerselvamNamasivayam Nalini
Aug 7, 2003·American Journal of Clinical Oncology·Asad UmarErnest T Hawk
Apr 23, 2002·Alimentary Pharmacology & Therapeutics·S OtaK Fujiwara
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gary J KelloffCaroline C Sigman
Dec 30, 2006·Journal of Lower Genital Tract Disease·Debra S Heller
Apr 7, 2007·Journal of Lower Genital Tract Disease·Amy MitchellFrancisco Garcia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.